Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon

American Journal of Surgery

Volumn 174, Issue 4, 1997, Pages 425-430

  Shpitz, Baruch ^a   Bomstein, Yonit ^a   Mekori, Yosi ^a   Cohen, Razia ^a   Kaufman, Zvi ^a   Grankin, Mila ^a,b   Bernheim, Joelle ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; METHYLENE BLUE; MONOCLONAL ANTIBODY;

ARTICLE; CELL KINETICS; COLON ADENOCARCINOMA; COLON ADENOMA; COLON POLYP; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMATOUS POLYPS; CARCINOMA IN SITU; CELL DIVISION; COLON; COLONIC NEOPLASMS; COLONIC POLYPS; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0030861397     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)00122-0     Document Type: Article

References (40)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.
2. Shpitz B, Medline A, Stern HS. The adenoma-carcinoma sequence. In: Mazier WP, Luchtenfield MA, Levien BH, Senagore AJ, eds. Surgery of Colon, Rectum and Anus. Philadelphia: WB Saunders; 1995:552-564.
3. Hall PA, Coates PJ. Assessment of cellular proliferation in pathology-what next? Histopathology. 1995;26:105-112.
4. Murakami MS, Strobel MC, Vande Voude GF. Cell cycle regulation, oncogenes, and antineoplastic drugs. In: Mendelsohn J, Howley PM, Israel MA, Liotta LA, eds. The Molecular Basis of Cancer. Philadelphia: WB Saunders; 1995:3-17.
5. Goodlad RA, Wright NA. Growth factors in the gastrointestinal tract. Bailliere's Clin Gastroenterol. 1990;4:97-118.
6. Baldwin GS, Whitehead RH. Gut hormones, growth and malignancy. Bailliere's Clin Endocrinol Metab. 1994;8:185-214.
7. Cohen SM, Ellwein LB. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 1991;51:6493-6505.
8. Risio M, Arrigoni A, Pennazio M, et al. Mucosal cell proliferation in patients with hyperplastic colorectal polyps. Scand J Gastroenterol. 1995;30:344-348.
9. Carr NJ, Monihan JM, Nzeako UC, et al. Expression of proliferating cell nuclear antigen in hyperplastic polyps, adenomas and inflammatory cloacogenic polyps of the large bowel. J Clin Pathol. 1995;48:46-52.
10. Al-Sheneber IF, Shibata HR, Sampalis J, Jothy S. Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer. 1993;71:1954-1959.
11. Quinn CM, Wright N A. The clinical assessment of proliferation and growth in human tumors: evaluation of methods and applications as prognostic variables. J Pathol. 1990; 160:93-102.
12. Yu CCW, Woods AL, Levison DA. The assessment of cellular proliferation by immunohistrochemistry: a review of currently available methods and their application. Histochem J. 1992;24:121-131.
13. Zuber M, Tan EM, Ryoji M. Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells. Moll Cell Biol. 1989;9:57-66.
14. Cellis JE, Cellis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA. 1985;82:3262-3266.
15. Linden MD, Ma CK, Kubus J, et al. Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinoma. Am J Clin Pathol. 1993;100:206-212.
16. Pelosi G, Bresaola E, Manfrin E, et al. Immunocytochemical detection of cell proliferation-related antigens in cytological smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67. Arch Pathol Lab Med. 1994;118:510-516.
17. Kawai T, Suzuki M, Kono S, et al. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Cancer. 1994;74:2468-2475.
18. Kubben FJCM, Peeters-Haesevoets A, Engels LGJB, et al. Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut. 1994;35:530-535.
19. McLellan EA, Bird RP. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res. 1988;48:6187-6192.
20. Pretlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res. 1991;51:1564-1567.
21. Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 1995;93:55-71.
22. Stopera SA, Murphy LC, Bird RP. Evidence for a ros gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis. 1992;13:2081-2085.
23. Vivona AA, Shpitz B, Medline A, et al. K-ros mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis. 1993;14:1777-1781.
24. Jen J, Powell SM, Papadopoulos N, et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 1994;54:5523-5526.
25. Pretlow TP, Cheyer C, O'Riordan MA. Aberrant crypt foci and colon tumors in F344 rats have similar increases in proliferative activity. Int J Cancer. 1994;56:599-602.
26. Pretlow TP, Roukhadze EV, O'Riordan MA, et al. Carcinoembryonic antigen in human colonic aberrant crypt foci. Gostroencerology. 1994;107:1719-1725.
27. Bland JM, Altman DO. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;i:307-310.
28. Otori K, Sugiyama K, Hasebe T, et al. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. Cancer Res. 1995;55:4743-4746.
29. Tomita T. DNA ploidy and proliferating cell nuclear antaigen in colonic adenomas and adenocarcinomas. Dig Dis Sci. 1995;40:996-1004.
30. Terpsta OT, van Blankenstein M, Dees J, Ellers GAM. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colonic adenoma or cancer. Gastroenterologe. 1987;92:704-708.
31. Pennazio M, Arrigoni A, Risio M, et al. Small rectosigmoid polyps as markers of proximal neoplasms. Dis Colon Rectum. 1993;36:1121-1125.
32. Rex DK, Smith JJ, Ulbright TM, Lehman GA. Distal colonic hyperplastic polyps do not predict proximal adenomas in asymptomatic average-risk subjects. Gastroenterologe. 1992;102:317-319.
33. Roncucci L, Pedroni M, Fante R, et al. Cell kinetic evaluation of human colonic aberrant crypts. Cancer Res. 1993;53:3726-3729.
34. Longacre TA, Genoglio-Preiser CM. Mixed hyperplastic ade-nomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14:524-537.
35. Hall PA, Levison DA. Review: assessment of cell proliferation in histological material. J Clin Pathol. 1990;43:184-192.
36. Hall PA, Levison DA, Woods AL, et al. Proliferataing cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 1990;162:285-294.
37. Risio M, Rossini FP. Cell proliferation in colorectal adenomas containing invasive carcinoma. Anaticancer Res. 1993;13:43-48.
38. Teixeira CR, Tanaka S, Haruma K, et al. Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer. 1994;73:575-579.
39. Collins RH, Feldman M, Fordtran JS. Colon cancer, dysplasia, and surveilance in patients with ulcerative colitis. A critical review. NEJM. 1987;316:1654-1658.
40. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet. 1994;343:71-74.